JP2023554500A5 - - Google Patents
Info
- Publication number
- JP2023554500A5 JP2023554500A5 JP2023537572A JP2023537572A JP2023554500A5 JP 2023554500 A5 JP2023554500 A5 JP 2023554500A5 JP 2023537572 A JP2023537572 A JP 2023537572A JP 2023537572 A JP2023537572 A JP 2023537572A JP 2023554500 A5 JP2023554500 A5 JP 2023554500A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- heavy chain
- chain monomer
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025197132A JP2026041774A (ja) | 2020-12-18 | 2025-11-18 | 四価ＦＺＤ及びＷＮＴコレセプター（ｃｏ－ｒｅｃｅｐｔｏｒ）結合抗体分子並びにその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063127408P | 2020-12-18 | 2020-12-18 | |
| US63/127,408 | 2020-12-18 | ||
| PCT/IB2021/061972 WO2022130342A1 (en) | 2020-12-18 | 2021-12-17 | Tetravalent fzd and wnt co-receptor binding antibody molecules and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025197132A Division JP2026041774A (ja) | 2020-12-18 | 2025-11-18 | 四価ＦＺＤ及びＷＮＴコレセプター（ｃｏ－ｒｅｃｅｐｔｏｒ）結合抗体分子並びにその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023554500A JP2023554500A (ja) | 2023-12-27 |
| JP2023554500A5 true JP2023554500A5 (enExample) | 2025-05-20 |
| JP7778148B2 JP7778148B2 (ja) | 2025-12-01 |
Family
ID=82058983
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023537572A Active JP7778148B2 (ja) | 2020-12-18 | 2021-12-17 | 四価ＦＺＤ及びＷＮＴコレセプター（ｃｏ－ｒｅｃｅｐｔｏｒ）結合抗体分子並びにその使用 |
| JP2023537540A Pending JP2024500839A (ja) | 2020-12-18 | 2021-12-17 | 四価ＦＺＤ及びＷＮＴコレセプター（ｃｏ－ｒｅｃｅｐｔｏｒ）結合抗体分子並びにその使用 |
| JP2025197132A Pending JP2026041774A (ja) | 2020-12-18 | 2025-11-18 | 四価ＦＺＤ及びＷＮＴコレセプター（ｃｏ－ｒｅｃｅｐｔｏｒ）結合抗体分子並びにその使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023537540A Pending JP2024500839A (ja) | 2020-12-18 | 2021-12-17 | 四価ＦＺＤ及びＷＮＴコレセプター（ｃｏ－ｒｅｃｅｐｔｏｒ）結合抗体分子並びにその使用 |
| JP2025197132A Pending JP2026041774A (ja) | 2020-12-18 | 2025-11-18 | 四価ＦＺＤ及びＷＮＴコレセプター（ｃｏ－ｒｅｃｅｐｔｏｒ）結合抗体分子並びにその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US20250270332A1 (enExample) |
| EP (3) | EP4263617A4 (enExample) |
| JP (3) | JP7778148B2 (enExample) |
| KR (1) | KR20230122077A (enExample) |
| CN (2) | CN116917332A (enExample) |
| AU (2) | AU2021404080A1 (enExample) |
| CA (2) | CA3204321A1 (enExample) |
| CL (2) | CL2023001768A1 (enExample) |
| IL (2) | IL303342A (enExample) |
| MX (1) | MX2023007103A (enExample) |
| WO (2) | WO2022130341A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11773171B2 (en) | 2017-12-19 | 2023-10-03 | Surrozen Operating, Inc. | WNT surrogate molecules and uses thereof |
| JP7377288B2 (ja) * | 2019-06-11 | 2023-11-09 | アントレラ セラピューティクス インコーポレイテッド | 多価ｆｚｄおよびｗｎｔ結合分子とその使用 |
| WO2023250402A2 (en) * | 2022-06-22 | 2023-12-28 | Antlera Therapeutics Inc. | Tetravalent fzd and wnt co-receptor binding antibody molecules and uses thereof |
| EP4457242A4 (en) * | 2021-12-31 | 2025-12-31 | Surrozen Operating Inc | SPECIFIC COMPOSITE OF A WNT RECEIVER AND ASSOCIATED METHOD |
| EP4547713A2 (en) * | 2022-06-30 | 2025-05-07 | The University of Chicago | Cd73 (nt5e) targeting polypeptides |
| WO2024227103A1 (en) * | 2023-04-27 | 2024-10-31 | Surrozen Operating, Inc. | Molecules modulating wnt signaling pathways and uses thereof |
| WO2025019458A2 (en) * | 2023-07-14 | 2025-01-23 | The Trustees Of Columbia University In The City Of New York | Specific blood retinal barrier defect in glaucoma directs new treatments and clinical tests |
| WO2025168716A1 (en) | 2024-02-07 | 2025-08-14 | Eyebiotech Limited | Compositions, doses, and methods for treatment of ocular diseases |
| WO2025176843A1 (en) | 2024-02-21 | 2025-08-28 | Ags Therapeutics Sas | Microalgae extracellular vesicle based gene therapy vectors (mev-gtvs), their preparation, and uses thereof |
| WO2026055308A1 (en) * | 2024-09-06 | 2026-03-12 | Merck Sharp & Dohme Llc | Multivalent fzd4, wnt co-receptor, and vegf receptor molecules and uses thereof |
| US20260092125A1 (en) * | 2024-09-06 | 2026-04-02 | Eyebiotech Limited | Multivalent fzd4, wnt co-receptor, and vegf binding molecules and uses thereof |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2095633C (en) | 1990-12-03 | 2003-02-04 | Lisa J. Garrard | Enrichment method for variant proteins with altered binding properties |
| EP1240319A1 (en) | 1999-12-15 | 2002-09-18 | Genentech, Inc. | Shotgun scanning, a combinatorial method for mapping functional protein epitopes |
| CA2488441C (en) | 2002-06-03 | 2015-01-27 | Genentech, Inc. | Synthetic antibody phage libraries |
| WO2004065416A2 (en) | 2003-01-16 | 2004-08-05 | Genentech, Inc. | Synthetic antibody phage libraries |
| US7785903B2 (en) | 2004-04-09 | 2010-08-31 | Genentech, Inc. | Variable domain library and uses |
| ES2577292T3 (es) | 2005-11-07 | 2016-07-14 | Genentech, Inc. | Polipéptidos de unión con secuencias hipervariables de VH/VL diversificadas y consenso |
| EP1973951A2 (en) | 2005-12-02 | 2008-10-01 | Genentech, Inc. | Binding polypeptides with restricted diversity sequences |
| TW200812616A (en) | 2006-05-09 | 2008-03-16 | Genentech Inc | Binding polypeptides with optimized scaffolds |
| CN100592373C (zh) | 2007-05-25 | 2010-02-24 | 群康科技(深圳)有限公司 | 液晶显示面板驱动装置及其驱动方法 |
| SG190568A1 (en) | 2008-09-26 | 2013-06-28 | Oncomed Pharm Inc | Frizzled-binding agents and uses thereof |
| US9200072B2 (en) | 2012-01-18 | 2015-12-01 | Genentech Inc. | Anti-LRP5 antibodies and methods of use |
| DE102012202081A1 (de) | 2012-02-13 | 2013-08-14 | Osram Gmbh | Glühfaden für elektrische lampen und elektrische lampe sowie herstellungsverfahren für einen glühfaden |
| US9862776B2 (en) | 2013-04-03 | 2018-01-09 | Peter Maccallum Cancer Institute | Antibodies against human RYK and uses therefor |
| US9237411B2 (en) | 2013-07-25 | 2016-01-12 | Elwha Llc | Systems and methods for providing one or more functionalities to a wearable computing device with directional antenna |
| US10077304B2 (en) | 2013-08-14 | 2018-09-18 | The Governing Council Of The University Of Toronto | Antibodies against frizzled receptor |
| ES2818103T3 (es) | 2015-01-16 | 2021-04-09 | Juno Therapeutics Inc | Anticuerpos y receptores de antígenos quiméricos específicos para ROR1 |
| WO2017127933A1 (en) | 2016-01-29 | 2017-08-03 | The Governing Council Of The University Of Toronto | Frizzled protein-binding agents and methods of use thereof |
| WO2018026942A1 (en) | 2016-08-02 | 2018-02-08 | Merrimack Pharmaceuticals, Inc. | Heteromeric polypeptides |
| US11039659B2 (en) | 2017-09-07 | 2021-06-22 | Nike, Inc. | Sole structure for article of footwear |
| JP7550647B2 (ja) * | 2018-02-14 | 2024-09-20 | アントレラ セラピューティクス インコーポレイテッド | Ｗｎｔシグナル伝達を活性化する多価結合分子およびその使用 |
| US20210292422A1 (en) | 2018-07-05 | 2021-09-23 | Surrozen, Inc. | Multi-specific wnt surrogate molecules and uses thereof |
| US10671121B2 (en) | 2018-09-14 | 2020-06-02 | Apple Inc. | Magnetic layout in electronic devices and accessory devices for electronic devices |
| JP7377288B2 (ja) * | 2019-06-11 | 2023-11-09 | アントレラ セラピューティクス インコーポレイテッド | 多価ｆｚｄおよびｗｎｔ結合分子とその使用 |
-
2021
- 2021-12-17 CA CA3204321A patent/CA3204321A1/en active Pending
- 2021-12-17 CA CA3204322A patent/CA3204322A1/en active Pending
- 2021-12-17 EP EP21905972.2A patent/EP4263617A4/en active Pending
- 2021-12-17 IL IL303342A patent/IL303342A/en unknown
- 2021-12-17 WO PCT/IB2021/061971 patent/WO2022130341A1/en not_active Ceased
- 2021-12-17 AU AU2021404080A patent/AU2021404080A1/en active Pending
- 2021-12-17 IL IL303344A patent/IL303344A/en unknown
- 2021-12-17 AU AU2021399278A patent/AU2021399278A1/en active Pending
- 2021-12-17 CN CN202180093862.1A patent/CN116917332A/zh active Pending
- 2021-12-17 WO PCT/IB2021/061972 patent/WO2022130342A1/en not_active Ceased
- 2021-12-17 JP JP2023537572A patent/JP7778148B2/ja active Active
- 2021-12-17 KR KR1020237023863A patent/KR20230122077A/ko active Pending
- 2021-12-17 US US18/267,914 patent/US20250270332A1/en active Pending
- 2021-12-17 CN CN202180093864.0A patent/CN116964102A/zh active Pending
- 2021-12-17 JP JP2023537540A patent/JP2024500839A/ja active Pending
- 2021-12-17 MX MX2023007103A patent/MX2023007103A/es unknown
- 2021-12-17 EP EP21905973.0A patent/EP4263618A4/en active Pending
-
2022
- 2022-06-22 US US17/846,846 patent/US20230118983A1/en active Pending
-
2023
- 2023-06-15 CL CL2023001768A patent/CL2023001768A1/es unknown
- 2023-06-22 EP EP23741240.8A patent/EP4543921A2/en active Pending
- 2023-11-03 US US18/501,589 patent/US20240228631A9/en not_active Abandoned
-
2025
- 2025-05-20 CL CL2025001491A patent/CL2025001491A1/es unknown
- 2025-11-18 JP JP2025197132A patent/JP2026041774A/ja active Pending